LeMaitre Vascular Inc (NAS:LMAT)
$ 105.47 -1.52 (-1.42%) Market Cap: 2.37 Bil Enterprise Value: 2.30 Bil PE Ratio: 57.63 PB Ratio: 7.16 GF Score: 85/100

LeMaitre Vascular Inc at UBS Global Healthcare Conference (Virtual) Transcript

May 20, 2020 / 12:20PM GMT
Release Date Price: $25.37 (+1.85%)
Matthew Charles Taylor
UBS Investment Bank, Research Division - Equity Research Analyst of Medical Supplies & Devices

Good morning, and thanks for joining us for our next session here at the UBS Virtual Global Healthcare Conference in the MedTech track. I'm Matt Taylor, UBS U.S. medical supplies and devices analyst. And I'm really pleased to be joined by management from LeMaitre Vascular. This morning, we have joining us, Dave Roberts, President of the company.

And for this session this morning, Dave is going to go through some opening comments to make a little bit of an overview of the company and what it's been going through, and then we'll move into a moderated Q&A session. As always, if you have questions that you want us to ask, please shoot me an e-mail or you can ask them through the webcast.

And with that, Dave, thanks for joining, and let me turn the floor to you.

David B. Roberts
LeMaitre Vascular, Inc. - President & Director

Thank you very much, Matt, and thanks to UBS for having LeMaitre Vascular present today. As

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investorsā€™ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot